Avelas Biosciences

Avelas Biosciences
San Diego, CA, USA
Year of Investment: 2016

Avelas Biosciences is a biotechnology company focused on creating better outcomes for cancer patients using proprietary platform technology of activatable cell-penetrating peptides (ACPPs).The most advanced product candidate combines ACPP platform with a fluorescent marker to create a real-time illuminated cancer map to assist the surgical oncologist during surgery. Additionally, ACPP platform can be used for the targeted delivery of small molecules and antibodies in the tumor environment, thus improving efficacy and tolerability of therapy.

For more information, please visit:
www.avelasbio.com

Avelas Biosciences Latest News
26.02.2020
Avelas Biosciences Voted Innovator of the Year at Field Service Medical 2020
22.11.2019
Avelas Welcomes Susan Stimson to its Board of Directors

Read more news

← Previous

TransMedics

Neon Therapeutics

Pharmstandard Ventures is looking for innovative drug discovery/development projects targeting the unmet medical needs or providing dramatic advantages over the competition globally

Back to Portfolio